在甲基酸诱导的超位运动中,二皮里达摩尔的抗精神效应类似于甲基酸
Anderson Gustavo Santos1, Carlos Eduardo Kühl1, Arisa Namie Higashijima1
1Laboratory of Physiology and Pharmacology of the Central Nervous System, Department of Pharmacology, Federal University of Paraná, Centro Politécnico, Curitiba, PR, Brazil.
Fundamental & clinical pharmacology
|March 12, 2024
概括
迪皮里达摩尔通过降低小鼠的甲基胺诱导的过活性,显示出一种类似于抗躁狂的效果. 这表明腺协同系统是新型抗躁狂药物开发的有希望的目标.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 精神病学是一个精神病学.
背景情况:
- 腺神经系统在双相情感障碍的病理生理学中发挥着作用.
- 腺素调节药物显示出作为躁狂症的附加治疗的潜力.
研究的目的:
- 为了选抗躁狂类效应的腺能药物.
- 在甲基酸盐 (MPH) 诱导的超位运动小鼠模型中研究效应.
主要方法:
- 小鼠接受了急性或14天反复给予的阿洛普林醇,二皮里达摩尔或伊诺辛.
- 超活性是由甲基化物 (MPH) 诱导的.
- 测量了运动运动活性,并使用氨基氨酸测试了腺素受体对抗性.
主要成果:
- 在急性和重复服药后,二皮里达摩尔显著降低了MPH诱导的多动性.
- 艾洛普里诺和因诺辛没有显著影响.
- 阿米诺菲林预处理阻断了迪皮里达摩尔的作用,表明腺受体参与.
结论:
- 迪皮里达摩尔表现出一种类似抗抑郁的作用,可能通过腺受体介导.
- 腺系统代表了新的抗躁狂药物的潜在治疗标.
相关概念视频
Adrenergic Agonists: Indirect-Acting Agents
1.6K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.6K
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
315
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
315
Parkinson's Disease: Treatment
268
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
268
Mania and Antimanic Drugs: Overview
179
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
179
Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
Drugs Acting on Autonomic Ganglia: Stimulants
1.3K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.3K


